GlassScriptPhysician profile
Quynhdiem Lam
NPI 1538652722
$4,110.57
in general payments reported to CMS, 2019-2025
8 companies · $1,490 in 2025
The $1,490 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.91 · 2023: $359 · 2024: $2,226 · 2025: $1,490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,756 · Travel and Lodging: $1,383 · Education: $936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,755.56 |
| Travel and Lodging | $1,383.48 |
| Education | $935.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,200.86 | 2024-2025 | Valiant Captivia, Endurant Iis |
| W. L. Gore & Associates, INC. | $988.17 | 2023-2025 | Gore Excluder Aaa Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Bard Peripheral Vascular, INC. | $605.88 | 2023-2024 | Lutonix Drug Coated Balloon |
| Cook Medical LLC | $171.09 | 2024-2025 | Zilver Ptx, Lunderquist, Zenith |
| Endologix LLC | $63.63 | 2025 | Alto Abdominal Stent Graft System |
| Medical Device Business Services, INC. | $35.91 | 2021 | |
| Baxter Healthcare | $28.52 | 2023 | Floseal |
| Ethicon US, LLC | $16.51 | 2024 | Echelon; Endopath, Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Quynhdiem Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.